GWEP1423: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in children and adults

Grants and Contracts Details

StatusFinished
Effective start/end date6/16/157/15/17

Funding

  • GW Research Limited: $126,043.00